Treatment options are preceded by a biopsy. A decision on performing a biopsy depends on PSA test results, a digital rectal exam, family history and age, as all of these are contributing factors. A tool of computing the risk of a positive biopsy may be used in the shared decision making process together with a specialized urologist or oncologist.
Once a pathology report after biopsy is obtained, the cancer will be classified as low, medium or high risk. The classification will usually be based on either the D'Amico classification or on the CAPRA score. In combination with nomograms predicting the probability of recurrence after treatment, these tools will be used in the personalized physician-patient decision on possible treatments.
There are a number of options for treating prostate cancer. For more descriptive details on these options see information provided by the National Prostate Cancer Coalition ("Zero").
See also articles on treatments, including Active Surveillance, in the PCa News Archives.